NASDAQ:ICU - Nasdaq - US81256L2034 - Common Stock - Currency: USD
SEASTAR MEDICAL HOLDING CORP
NASDAQ:ICU (2/4/2025, 8:00:02 PM)
Premarket: 1.85 -0.06 (-3.14%)1.91
-0.37 (-16.23%)
The current stock price of ICU is 1.91 USD. In the past month the price decreased by -9.05%. In the past year, price decreased by -91.12%.
Let's have a look at the stocks with an unusual volume in today's session.
DENVER, Feb. 03, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) today announced the closing of its...
DENVER, Jan. 31, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) today announced it has entered into a...
DENVER, Jan. 22, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing...
Study to be conducted under $3.6 million NIH grant DENVER, Jan. 13, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a...
DENVER, Jan. 08, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing...
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 27.64 | 223.92B | ||
ISRG | INTUITIVE SURGICAL INC | 79.08 | 206.46B | ||
BSX | BOSTON SCIENTIFIC CORP | 43.87 | 152.60B | ||
SYK | STRYKER CORP | 32.19 | 149.59B | ||
MDT | MEDTRONIC PLC | 17.33 | 116.65B | ||
BDX | BECTON DICKINSON AND CO | 18.42 | 70.30B | ||
EW | EDWARDS LIFESCIENCES CORP | 26.72 | 42.07B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 20.6 | 39.72B | ||
IDXX | IDEXX LABORATORIES INC | 41.34 | 38.08B | ||
RMD | RESMED INC | 27.2 | 35.30B | ||
DXCM | DEXCOM INC | 51.45 | 34.16B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 20.23 | 25.29B |
SeaStar Medical Holding Corp is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Denver, Colorado and currently employs 12 full-time employees. The company went IPO on 2021-01-26. SeaStar Medical Holding Corporation is a commercial-stage medical technology company. The firm is focused on developing extracorporeal therapies to reduce the consequences of hyperinflammation on vital organs. The firm's technologies rely on science to provide life-saving solutions to critically ill patients. The firm develops and commercializes cell-directed extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The firm uses its Selective Cytopheretic Device (SCD) technology platform to clinically validate several acute organ injury indications, including kidneys and lungs. Its investigational SCD is an extracorporeal synthetic membrane device designed to integrate into existing continuous renal replacement therapy (CRRT) systems that are commonly installed in hospitals throughout the United States.
SEASTAR MEDICAL HOLDING CORP
3513 Brighton Blvd, Suite 410
Denver COLORADO US
Employees: 12
Company Website: https://seastarmedical.com
Investor Relations: https://investors.seastarmedical.com/overview/default.aspx
Phone: 18444278100
The current stock price of ICU is 1.91 USD.
The exchange symbol of SEASTAR MEDICAL HOLDING CORP is ICU and it is listed on the Nasdaq exchange.
ICU stock is listed on the Nasdaq exchange.
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for ICU, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of ICU.
ICU does not pay a dividend.
ICU does not have a PE ratio as the earnings reported over the last twelve months were negative (-12.38).
The outstanding short interest for ICU is 9.73% of its float.
Over the last trailing twelve months ICU reported a non-GAAP Earnings per Share(EPS) of -12.38. The EPS decreased by -16.01% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -660.4% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 80% to ICU. The Buy consensus is the average rating of analysts ratings from 5 analysts.